These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 31444171)

  • 21. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rapid detection of rifampin resistance of Mycobacterium tuberculosis using high-throughput pyrosequencing technique].
    Zhao JR; Bai YJ; Wang Y; Zhang QH; Luo M; Yan XJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):297-300. PubMed ID: 15949307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay.
    Niward K; Ek Blom L; Davies Forsman L; Bruchfeld J; Eliasson E; Schön T; Chryssanthou E; Paues J
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
    Peloquin CA; Velásquez GE; Lecca L; Calderón RI; Coit J; Milstein M; Osso E; Jimenez J; Tintaya K; Sanchez Garavito E; Vargas Vasquez D; Mitnick CD; Davies G
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility.
    Tortoli E; Marcelli F
    Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):51-5. PubMed ID: 17180347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Kaushik A; Makkar N; Pandey P; Parrish N; Singh U; Lamichhane G
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6561-7. PubMed ID: 26259792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB).
    Kim BJ; Lee KH; Yun YJ; Park EM; Park YG; Bai GH; Cha CY; Kook YH
    J Microbiol Methods; 2004 Jul; 58(1):111-8. PubMed ID: 15177909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of rpoB gene mutations in Mycobacterium tuberculosis].
    Yin LF; Lu XD; Meng SJ; Wang R
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):185-9. PubMed ID: 16944591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons.
    Liu L; Xu Y; Shea C; Fowler JS; Hooker JM; Tonge PJ
    J Med Chem; 2010 Apr; 53(7):2882-91. PubMed ID: 20205479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging Chronic Tuberculous Lesions Using Sodium [(18)F]Fluoride Positron Emission Tomography in Mice.
    Ordonez AA; DeMarco VP; Klunk MH; Pokkali S; Jain SK
    Mol Imaging Biol; 2015 Oct; 17(5):609-14. PubMed ID: 25750032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons.
    El-Hajj HH; Marras SA; Tyagi S; Kramer FR; Alland D
    J Clin Microbiol; 2001 Nov; 39(11):4131-7. PubMed ID: 11682541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary nasal tuberculosis as the origin of submaxillary adenopathy.
    Rovira Casas A; González-Compta FX; Vega-Céliz JL; Cisa Lluis E
    Acta Otorrinolaringol Esp; 2015; 66(6):e35-7. PubMed ID: 25107356
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.
    de Steenwinkel JE; Aarnoutse RE; de Knegt GJ; ten Kate MT; Teulen M; Verbrugh HA; Boeree MJ; van Soolingen D; Bakker-Woudenberg IA
    Am J Respir Crit Care Med; 2013 May; 187(10):1127-34. PubMed ID: 23525933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rifapentine: its role in the treatment of tuberculosis.
    Temple ME; Nahata MC
    Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
    Park SW; Tasneen R; Converse PJ; Nuermberger EL
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
    Peloquin CA; Velásquez GE; Lecca L; Calderón RI; Coit J; Milstein M; Osso E; Jimenez J; Tintaya K; Garavito ES; Vasquez DV; Mitnick CD; Davies G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28839086
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.